Phase II clinical trial assessing the addition of hyperthermia to salvage concurrent chemoradiotherapy for unresectable recurrent head and neck cancer in previously irradiated patients
Abstract Background This single-arm phase II trial aimed to assess the effectiveness and safety of incorporating hyperthermia into salvage concurrent chemoradiotherapy (CCRT) for previously irradiated unresectable recurrent head and neck cancer. Methods We enrolled patients with non-metastatic recur...
| Published in: | Radiation Oncology |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13014-025-02585-z |
